DABRA Laser (RA-308 Excimer Laser). The DABRA Laser and DABRA Catheter is an excimer laser ultrav...

FDA Device Recall #Z-2497-2020 — Class II — January 23, 2020

Recall Summary

Recall Number Z-2497-2020
Classification Class II — Moderate risk
Date Initiated January 23, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Ra Medical Systems, Inc.
Location Carlsbad, CA
Product Type Devices
Quantity 79 units

Product Description

DABRA Laser (RA-308 Excimer Laser). The DABRA Laser and DABRA Catheter is an excimer laser ultraviolet light source and delivery system, collectively the DABRA Laser System". The system is designed to deliver the energy to the surgical site to ablate unwanted material. The optical conduit is used in conjunction with existing endovascular accessories and tools to complete a surgical procedure. The software is programmed onto an EEPROM chip, which is a component of the DABRA Excimer Laser RA-308 system. Catheter for crossing total occlusions in vascular system.

Reason for Recall

A software issue was identified which could result in user or patient injury, or may adversely impact laser performance. It is possible that an unintended release of laser light (radiation) may occur, injuring the user or patient.

Distribution Pattern

US: AL, AZ, CA, FL, GA, ID, IL, IN, KS, KY, LA, MI, MD, NC, NV, NY, OK, OR, PA, TN,TX, WI. OUS: Italy and Japan.

Lot / Code Information

Serial Number(s): RA00027 through RA00176;all DABRA excimer laser RA-308 product is impacted.

Other Recalls from Ra Medical Systems, Inc.

Recall # Classification Product Date
Z-0569-2021 Class II DABRA Laser (RA-308 Excimer Laser) Intended ... Oct 16, 2020
Z-0050-2021 Class II DABRA RA-308 Excimer Laser, SN: ******* - Produ... Jul 24, 2020
Z-2006-2020 Class II Ra Medical Systems DABRA Catheter 5F (1.5mm), R... Sep 19, 2019
Z-1631-2020 Class II Pharos Excimer Laser, Model: EX-308 - Product U... Aug 23, 2019

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.